2076975 2077203
최종편집 2022-01-28 15:51 (금)
Ezetimibe listed the most in the K-Orange Book in 2021
상태바
Ezetimibe listed the most in the K-Orange Book in 2021
  • Hyeokgi Lee, Newsmp
  • 승인 2022.01.13 23:51
  • 댓글 0
이 기사를 공유합니다

189 cases out of 1151 cases… Rivaroxaban 145ㆍAtorvastatin 143

Among the 1151 drugs listed in the Korean version of Orange Book last year, Statin plus Ezetimibe combination drugs accounted for more than 300 cases.

According to the Ministry of Food and Drug Safety’s information platform (https://nedrug.mfds.go.kr/), the most registered in the K-Orange Book based on its main ingredients was Ezetimibe drugs, 189 cases out of 1151 cases.

Following Ezetimibe, Rivaroxaban had 145 cases, Atorvastatin 143 cases, and Sitagliptin 106 cases, exceeding 100 cases.

Among them, most of the Ezetimibe and Atorvastatin drugs were listed as combinations, but either Ezetimibe or Atorvastatin was listed as the main ingredient, and in fact, there were more than 300 cases of Atorvastatin plus Ezetimibe combinations.

Twenty-five cases of Pitavastatin and 17 cases of Rosuvastatin were listed, and many of them were also Ezetimibe combinations.

Following the four ingredients that exceeded 100, the Empagliflozin was close to 100 by 97 cases.

Telmisartan had 36 cases, and Donepezil, Mirabegron, Esomeprazole, and Tofacitinib were 26 cases.

There were 25 cases of Pitavastatin, 20 cases of Amlodipine, 18 cases of Fluoxetine, and 17 cases of Levodropropizine and Rosuvastatin.

Moreover, Teneligliptin recorded 14 cases, Dobesilate and Vildagliptin 12 cases, Tadalafil and Topiramate 11 cases, and Etoricoxib and Finasteride 10 cases.
 


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.